Tempest Therapeutics, Inc.
TPST
Amendment
Ownership
3.70%
Total Shares
162,972
Issuer CIK
1544227
CUSIP
87978U108
Event Date
Aug 10, 2025
Accepted
Aug 13, 2025, 07:14 PM
SEC EDGARView Original Filing
Reporting Persons (9)
Joint Filing
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Vantage II, L.P. | Partnership | 3.70% | 162,972 | 162,972 | 0 |
| Versant Vantage II GP-GP, LLC | Other | 3.70% | 162,972 | 0 | 162,972 |
| Versant Vantage II GP, L.P. | Partnership | 3.70% | 162,972 | 0 | 162,972 |
| Versant Ventures IV, LLC | Other | 2.00% | 90,651 | 0 | 90,651 |
| Versant Venture Capital IV, L.P. | Partnership | 2.00% | 90,084 | 90,084 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 0.40% | 16,149 | 0 | 16,149 |
| Versant Venture Capital VI, L.P. | Partnership | 0.40% | 16,149 | 16,149 | 0 |
| Versant Ventures VI GP-GP, LLC | Other | 0.40% | 16,149 | 0 | 16,149 |
| Versant Side Fund IV, L.P. | Partnership | 0.00% | 567 | 567 | 0 |
Disclosure Items (2)
Security Title
Common Stock, par value $0.001 per share
Issuer Name
Tempest Therapeutics, Inc.
Issuer Address
2000 Sierra Point Parkway, Brisbane, CA, 94005
Percentage of Class
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
Number of Shares
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.